Danielle Masterson

Women’s healthcare company Bonafide Health recently released results from its annual State of Menopause report. The in-depth survey tracks longitudinal shifts in perceptions surrounding menopause that informs how women are experiencing and navigating perimenopause and menopause.

This week Levelle Nutrition launched its Cycle Syncing Protein, the first protein powder intentionally developed to support the shifting nutritional needs of menstruating women throughout their cycle. The launch marks an important shift in the market by addressing a critical gap and offering a clinically informed, phase-based solution tailored to the female body.

A systematic review and network meta-analysis recently published in Frontiers examined the effectiveness of various dietary supplements on athletic performance. The research focused on supplements like protein, creatine, beta-alanine, HMB, vitamin D and caffeine. The goal was to identify supplements that would offer the greatest benefit for athletes and help inform coaches and sports nutritionists when developing supplementation plans.

Professional golfer Ben Griffin made headlines this week for an alleged overdose—sparking a very spirited conversation among the creatine science community.

By now, many have heard of the gut-brain axis, the gut-skin axis and more. But what about the gut-hormone axis? This refers to the bidirectional communication system between the gut and the endocrine system. For women specifically, this is the estrobolome. Kaneka Probiotics recently launched KABP Menopause, a probiotic that modulates the estrobolome. To hear more on how that works, Jordi Riera, Chief Business Officer at Kaneka Probiotics, joined the NutraCast.

NutraCast: Beyond prenatals: Folate’s crucial role in methylation, women’s health and more

The women driving sustainability

The Council for Responsible Nutrition is ringing the alarm on two bills, one impacting pregnant women in California, the other, minors in New York. While the bills appear to be well-intentioned, CRN says they could result in unintended consequences for women, babies and commerce.

Jeffersonville, Indiana is now home to BioVivo Science’s new facility, marking a major shift from overseas dependency to domestic production. The $70 million investment into the new 100,000-square-foot facility will allow Biovivo to process 2,000 metric tons of botanicals annually—and the company says it's just getting started.

September's new launches highlight a focus on women’s hormonal health, sports nutrition, hydration, gut health and beauty-from-within.